📉 Washington market decline, NY dispensary lawsuits, Ohio festival chaos

Welcome back from the weekend!

Built by a former cannabis regulator, Policy, Decoded is your high-signal daily briefing for operators, investors, and policymakers navigating the collision of law, regulation, and business.

We of course want to thank our sponsor The Daily Upside for supporting today’s edition. Want to get your brand, company, services, or programs in front of thousands of cannabis policy leaders and wonks? Reach out anytime.

The cannabis industry's structural vulnerabilities came into sharp focus this week as Washington's five-year market decline exposed the impossibility of sustaining isolated state systems within interconnected regional economies. While operators in the Pacific Northwest grapple with oversupply cascading across state borders, New York dispensaries sued regulators over measurement errors threatening 152 licensed businesses, and an Ohio cannabis festival devolved into what one vendor described as "The Walking Dead." These developments underscore a critical inflection point where regulatory incompetence meets economic reality, forcing executives to navigate markets shaped as much by neighboring states as local policy failures.

🎯 Know your borders.
📊 Prepare for consolidation.
📬 Forward to your ops team.

Start smarter. Move faster. Stay ahead.

📌 What Happened: Washington's cannabis market is bleeding money for the fifth straight year, with Q1 2025 revenue dropping to $280 million from a pandemic peak of $370 million in 2021, even as dispensaries multiplied from 400 to over 600 statewide. Shawn Kemp's Cannabis in Seattle now hawks deals up to 65% off with promotions like "Munchie Monday" and "Wax Wednesday," while manager Tran Du watches monthly sales crater from $700,000 during the pandemic to $500,000 today. The culprit is a perfect storm of oversupply and punitive taxation, with Washington's 37% excise tax combining with sales tax to create a crushing 47% burden that's driving what one industry veteran calls "the cheapest market by far" compared to California and Nevada. State tax revenue dropped from $555.4 million in 2021 to $454.7 million in 2024, an 18% decline that has lawmakers watching their cannabis windfall evaporate in real time. (The Spokesman-Review, KOMO News

💡 Why It Matters: Washington's problems can't be understood in isolation from the broader West Coast cannabis market, where Oregon's oversupply crisis and California's illicit market competition create a regional race to the bottom. Despite federal prohibition on interstate commerce, proximity drives everything from talent migration to consumer expectations, with operators and customers inevitably influenced by neighboring market conditions. Washington's tax burden becomes particularly brutal when consumers near Oregon can access similar products for less, while industry professionals flee to markets with better business fundamentals and opportunities. The state created this dynamic by treating licenses like lottery tickets, limiting them initially to create artificial scarcity, then opening the floodgates without considering whether the region could absorb multiple oversupplied markets competing for the same customers.

🚨 New York dispensaries sue state over measurement bungle that threatens 152 businesses

A dozen cannabis operators filed suit Friday challenging New York's attempt to retroactively enforce proximity rules after regulators admitted they incorrectly measured the required 500-foot school buffer for over 152 licensed dispensaries for years. The Office of Cannabis Management had been measuring from school entrances rather than property lines, a mistake discovered during a review by interim director Felicia Reid, who apologized but said legislative intervention is needed to prevent mass relocations. With 89 percent of affected dispensaries owned by social equity applicants who "poured their life savings" into businesses under state-approved frameworks, the lawsuit seeks to block retroactive enforcement that Housing Works president Matthew Bernardo warns would be "a fatal blow to legal cannabis." Governor Hochul called it "a major screw-up" and promised to work with lawmakers, but the proposed 2026 legislative fix offers little relief for operators bleeding cash now. (New York Times)

🚫 Anti-rescheduling advocates push flawed arguments as Trump weighs cannabis policy

Drug policy researcher Angel Gomez delivers a masterclass in prohibition logic, arguing against rescheduling marijuana because today's cannabis is somehow more dangerous than the "traditional forms" with 2-4% THC that built the foundation for mass incarceration. His argument creates a perfect Catch-22: Schedule 1 classification has blocked the medical research he demands as justification for reform, then he cites the resulting evidence gap to argue against changing the classification that prevented the research in the first place. Gomez's proposal to maintain Schedule 1 for high-THC products while allowing research on cannabis below 4% ignores that this arbitrary threshold would exclude most therapeutic applications patients actually use. The real agenda shows when he frames eliminating 280E tax penalties as corporate welfare rather than basic business equity, apparently believing cannabis companies should remain the only legal industry operating under tax burdens designed for cartels. These talking points reflect the political pressure facing Trump from prohibition dead-enders who would rather maintain a failed drug war than admit decades of policy mistakes, wrapping outdated ideology in the language of public health while ignoring that rescheduling would enable the FDA oversight they claim to want. (The Hill)

🧪 Suspended Massachusetts cannabis testing lab reaches agreement with regulators to resume operations

Assured Testing Laboratories reached an agreement with the Massachusetts Cannabis Control Commission to lift its June suspension for allegedly downplaying contaminant levels, requiring CEO replacement, a $300,000 fine, and two years probationary oversight without admitting wrongdoing. The settlement affects over 7,000 potentially contaminated marijuana products tested between April 2024 and April 2025, with the Commission issuing a public health advisory requiring consumers to cross-reference package labels with contaminated product lists rather than ordering a mandatory recall. Cannabis advocates criticized the consumer-responsibility approach as inadequate protection for immunocompromised patients who face life-threatening infection risks from contaminated cannabis. The case highlights widespread industry problems with testing labs "changing yeast and mold measurements to ensure higher pass rates" to attract cultivator business, with similar recalls occurring in New York and Missouri. Despite the financial penalties and leadership changes, Assured stated it "disagrees with aspects of how we got here" while expressing eagerness to return to operations. (The Boston Globe)

🧪 Texas crime labs warn they lack resources to enforce hemp THC restrictions as lawmakers consider ban

Texas crime lab officials testified Wednesday that they cannot adequately enforce whatever hemp regulations lawmakers pass, whether it's House Bill 5's proposed ban on products containing "any detectable amount of any cannabinoid" beyond CBD and CBG or alternative regulatory approaches. Houston Forensic Science Center CEO Peter Stout told the House Public Health Committee that with only 266 licensed drug chemists statewide and backlogs reaching hundreds to thousands of cases deep, "I'm going to prioritize the fentanyl before hemp, and every dollar I spend on testing drugs is a dollar I don't have to spend on testing a sexual assault kit". The enforcement dilemma creates a no-win scenario where a complete ban would make testing easier but increase caseloads, while regulation requiring detection of permissible THC levels would be more expensive and time-consuming for already overwhelmed laboratories. Crime labs need around $2,500 per case in funding but only receive about $600, with no pipeline of trained chemists available to address workforce shortages. The resource crisis effectively renders any hemp policy unenforceable, highlighting how regulatory ambition collides with operational reality in cash-strapped state systems. (Marijuana Moment, The Texas Tribune)

🏛️ Delaware governor consults Colorado on cannabis regulation despite vastly different market realities

Delaware Governor Matt Meyer is seeking regulatory advice from Colorado Governor Jared Polis as the state's adult-use cannabis market launches, despite fundamental differences that make Colorado's approach largely irrelevant to Delaware's tiny three-county geography. Polis advised Meyer to "just let the counties do it" because he has "too many counties" to track, admitting "I have no idea" about local regulations and saying "some do it, some don't, I don't really know" about his own state's patchwork system. Meyer acknowledged Delaware's spatial constraints make Colorado's approach unworkable, noting Colorado's "three-mile limitation from schools" would be problematic in a state where restrictive local zoning could effectively ban all cannabis businesses. The governor emphasized his priority of avoiding the "stench" he associates with New York and San Francisco cannabis markets, declaring "that's not Delaware" while weighing legislation to override local zoning authority. This consultation highlights a persistent flaw in cannabis policy development where states reflexively look to early adopters rather than examining markets with similar demographics, geography, and regulatory structures that would provide more relevant guidance for implementation challenges. (Marijuana Moment)

💨 Santa Barbara DA secures $620K settlement against Central Coast Agriculture for illegal diesel generator operation

Santa Barbara County's $620,000 settlement against Central Coast Agriculture for operating 16 unpermitted diesel generators exposes a critical blind spot in cannabis regulatory enforcement that could reshape how operators approach infrastructure investments. The generators powered refrigeration units storing frozen cannabis and greenhouse cultivation for over 12 months without Air Pollution Control District permits, violating California Air Resources Board regulations designed to track emissions from portable equipment. What makes this settlement strategically significant is the precedent it sets for prosecuting infrastructure shortcuts that operators commonly use to avoid costly grid connections and permitting delays. APCD Executive Director Aeron Arlin Genet's emphasis on "serious violations" affecting "human health" and the rarity of cases forwarded to prosecutors signals a hardening enforcement stance that could trigger audits of similar operations statewide. With $260,000 of penalties funding future environmental enforcement and operators increasingly squeezed between compliance costs and profitability pressures, expect this case to drive immediate infrastructure assessments across California's cultivation sector as companies realize that cutting corners on air quality permits now carries six-figure liability exposure. (Santa Barbara County District Attorney's Office)

🎪 Ohio cannabis festival turns into "Walking Dead episode" as vendors flee mismanaged event

The second annual Stargazer Cannabis Festival in Waverly, Ohio collapsed into chaos after organizer Chad Thompson confirmed the July venue just days before the event, leaving vendors scrambling when flooding forced last-minute relocations away from promised electrical access. Food truck owner Jennifer Carlson lost hundreds in spoiled inventory after paying $800 for vendor fees plus $50 for power that never materialized, while artist Hannah Anderson described the scene as looking "like an episode of 'The Walking Dead'" and fled the same day she arrived. Vendors reported feeling "completely unsafe" due to metal shards on activity beaches, children present despite Thompson's claimed "21 and up" policy, and security that allegedly hung up on a young girl seeking help for a friend having a bad drug experience. Thompson dismissed safety allegations as "completely made up" and claimed most vendors were satisfied, despite the festival failing to turn a profit and numerous vendors reporting thousands in losses. The disaster exposes how inexperienced operators can exploit the cannabis community's enthusiasm while delivering experiences that damage the industry's credibility and endanger participants. (Local 12, WCMH)

🏥 France advances plans to fully integrate medical cannabis into pharmaceutical healthcare system by Q1 2026

France submitted three documents to the EU in March detailing a comprehensive medical cannabis framework that integrates directly into existing pharmaceutical regulations rather than creating standalone cannabis pathways, targeting five strictly last-line indications including refractory neuropathic pain and drug-resistant epilepsy. The Haute Autorité de Santé published a roadmap on July 29 outlining evaluation processes for reimbursement structures, with public consultation running through September 16 and final recommendations expected by Q1 2026. Unlike other European markets, France excludes raw flower (except sealed-vape formats) and requires all cultivators, importers, and processors to either be registered pharmaceutical entities or partner with existing "exploitant pharmaceutique" companies. Industry experts from Augur Associates and Newsweed believe the pharmaceutical approach will "reduce stigma and improve access" while creating a "durable and exportable framework" that could influence forthcoming EU supra-regulation, with Prohibition Partners projecting the market could reach €806 million by 2035. The system leverages 2,000-3,000 already-trained healthcare professionals from the pilot program and allows specialist-initiated prescriptions to transfer to general practitioners for ongoing care. (Cannabis Health News)